The present invention relates to compounds of formula I,
##STR1##
in which R0; R1; R2; R3; R4;
R5; R6; R7; Q; V, G and M have the meanings indicated
in the claims. The compounds of formula I are valuable pharmacologically active
compounds. They exhibit a strong antithrombotic effect and are suitable, for example,
for the therapy and prophylaxis of cardiovascular disorders like thromboembolic
diseases or restenoses. They are reversible inhibitors of the blood clotting enzymes
factor Xa (FXa) and/or factor VIIa (FVIIa), and can in general be applied in conditions
in which an undesired activity of factor Xa and/or factor VIIa is present or for
the cure or prevention of which an inhibition of factor Xa and/or factor VIIa is
indicated. The invention furthermore relates to processes for the preparation of
compounds of formula I, their use, in particular as pharmaceuticals for treating
the foregoing conditions, and pharmaceutical preparations comprising them.
